Utah Medical Products, Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $21.1M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $809.0K | 3.8% |
| Other Investing | $9.0K | 0.0% |
| Dividends Paid | $3.2M | 15.0% |
| Stock Repurchases | $2.5M | 11.8% |
| Other | $593.0K | 2.8% |
| Net Cash Flow | $14.1M | 66.6% |